Biogen Inc (BIIB)
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
Eastman Chemical Company - Eastman Schedules Fourth-Quarter and Full-Year 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information
Natera - Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
New to Diverse: a SWE Podcast? Start Here!